581.74
1.44%
-8.52
After Hours:
580.91
-0.83
-0.14%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corporation stock is traded at $581.74, with a volume of 577.14K.
It is down -1.44% in the last 24 hours and down -0.38% over the past month.
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$590.26
Open:
$588.97
24h Volume:
577.14K
Relative Volume:
0.74
Market Cap:
$73.85B
Revenue:
$330.19B
Net Income/Loss:
$2.54B
P/E Ratio:
30.13
EPS:
19.31
Net Cash Flow:
$4.31B
1W Performance:
+0.74%
1M Performance:
-0.38%
6M Performance:
-0.87%
1Y Performance:
+20.27%
Mckesson Corporation Stock (MCK) Company Profile
Name
Mckesson Corporation
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
581.74 | 73.85B | 330.19B | 2.54B | 4.31B | 19.31 |
COR
Cencora Inc
|
236.19 | 45.65B | 293.96B | 1.51B | 3.00B | 7.51 |
CAH
Cardinal Health Inc
|
121.57 | 29.42B | 224.34B | 1.26B | 1.08B | 5.14 |
HSIC
Henry Schein Inc
|
69.67 | 8.69B | 12.50B | 314.00M | 421.00M | 2.44 |
PDCO
Patterson Companies Inc
|
30.81 | 2.72B | 6.55B | 155.22M | -823.13M | 1.71 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-04-24 | Resumed | Mizuho | Neutral |
Nov-07-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
Sep-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
Sep-05-24 | Reiterated | Leerink Partners | Outperform |
Aug-08-24 | Reiterated | Mizuho | Neutral |
Feb-26-24 | Initiated | Leerink Partners | Outperform |
Jan-03-24 | Initiated | Barclays | Overweight |
Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
Mar-31-23 | Initiated | Citigroup | Buy |
Aug-22-22 | Resumed | Morgan Stanley | Overweight |
Jul-06-22 | Downgrade | Argus | Buy → Hold |
Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
Apr-01-22 | Resumed | Credit Suisse | Outperform |
Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
Nov-02-21 | Reiterated | Barclays | Overweight |
Nov-02-21 | Reiterated | BofA Securities | Buy |
Nov-02-21 | Reiterated | Evercore ISI | Outperform |
Nov-02-21 | Reiterated | Jefferies | Buy |
Mar-30-21 | Upgrade | Argus | Hold → Buy |
Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
May-15-20 | Upgrade | UBS | Neutral → Buy |
Apr-23-20 | Resumed | Credit Suisse | Neutral |
Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Sep-12-19 | Initiated | Deutsche Bank | Hold |
Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Jul-22-19 | Initiated | Guggenheim | Neutral |
Jan-17-19 | Initiated | UBS | Neutral |
Oct-26-18 | Reiterated | Barclays | Equal Weight |
Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
Mar-08-18 | Initiated | Barclays | Equal Weight |
Feb-27-18 | Resumed | BofA/Merrill | Buy |
Feb-02-18 | Reiterated | Mizuho | Neutral |
Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corporation Stock (MCK) Latest News
McKesson (NYSE:MCK) Given New $677.00 Price Target at Citigroup - MarketBeat
Wealth Enhancement Advisory Services LLC Acquires 1,260 Shares of McKesson Co. (NYSE:MCK) - MarketBeat
Hilltop National Bank Reduces Stock Position in McKesson Co. (NYSE:MCK) - MarketBeat
McKesson Amplify provides funding to state pharmacy associations for advocacy - Drug Store News
International Assets Investment Management LLC Trims Stock Position in McKesson Co. (NYSE:MCK) - MarketBeat
Ambulatory Infusion Center Market Set to Witness Significant Growth by 2025-2032: McKesson - EIN News
2024 Research Report: Care Management Solutions Market Projected to Reach USD 67.02 Billion by 2035 - GlobeNewswire Inc.
Laboratory Informatics Market Projected To Witness Substantial Growth, 2025-2032:McKesson Corporation,Abbott - EIN News
Healthcare Distribution Market Set to Witness Significant Growth by 2025-2032:McKesson Corporation, Cardinal - EIN News
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
McKesson launches initiative to boost pharmacy advocacy - HME News
Stan Wong's Past Picks: Mastercard, McKesson Corp. and O'Reilly Automotive - BNN Bloomberg
McKesson Amplify Initiative Secures Funding for State Pharmacy Associations - Drug Topics
TD Cowen lifts McKesson stock target, retains Buy on strategic moves - Investing.com
Park National Corp OH Sells 1,404 Shares of McKesson Co. (NYSE:MCK) - MarketBeat
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Value-Based Healthcare Market Set to Witness Significant Growth by 2025-2032: McKesson Corporation, Deloitte, - EIN News
McKesson (MCK) Gains As Market Dips: What You Should Know - Yahoo Finance
Container Services to relocate to former McKesson plant - New Castle News
Diversified Trust Co Has $4 Million Stock Position in McKesson Co. (NYSE:MCK) - MarketBeat
Healthcare Distribution Market Set to Witness Significant Growth by 2024-2031 | McKesson Corporation, Dakota - EIN News
McKesson Amplify Empowers State Pharmacy Associations Nationwide with Advocacy Funding - Business Wire
Digital Healthcare Market Set to Witness Significant Growth by 2025-2032:Apple Inc., Oracle Cerner, Mckesson - EIN News
McKesson Corp. stock rises Monday, still underperforms market - MarketWatch
Bank of America Issues Pessimistic Forecast for McKesson (NYSE:MCK) Stock Price - MarketBeat
McKesson completes divestiture of Canada-based Rexall, Well.ca - Drug Store News
Pensionfund Sabic Buys 1,200 Shares of McKesson Co. (NYSE:MCK) - MarketBeat
Insider Selling: McKesson Co. (NYSE:MCK) EVP Sells 579 Shares of Stock - MarketBeat
McKesson's chief HR officer Leann Smith sells shares for $331,645 - Investing.com
Everence Capital Management Inc. Lowers Stake in McKesson Co. (NYSE:MCK) - MarketBeat
McKesson | We Are McKesson [c039e0] - Fathom Journal
McKesson Stock Declines Post Divestiture of Canada-Based Businesses - Yahoo Finance
Enterprise Medical Image Viewers Market Top PlayersMcKesson - openPR
Jim Cramer’s Take on McKesson Corporation (MCK): Bold Predictions for the Future - Insider Monkey
McKesson completes sale of Rexall and Well.ca businesses to Birch Hill - Private Capital Journal
McKesson Corporation Completes Divestiture of Canada-Based Rexall and Well.ca Businesses - BioSpace
McKesson sells Rexall and Well.ca to focus on healthcare By Investing.com - Investing.com Australia
McKesson sells Rexall and Well.ca to focus on healthcare - Investing.com
McKesson Completes Strategic Sale of Rexall, Well.ca to Focus on Oncology and Biopharma Growth - StockTitan
McKesson will close its medical distribution center in Rock Hill amid industry challenges - The Post and Courier
Why McKesson (MCK) is a Top Value Stock for the Long-Term - Yahoo Finance
Investing in McKesson (NYSE:MCK) five years ago would have delivered you a 333% gain - Yahoo Finance
McKesson Corporation Announces Third Quarter Fiscal 2025 Earnings Release Date and Participation in January Conference - The Bakersfield Californian
Patient Engagement Solutions Market Key Players Analysis - openPR
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know - MSN
McKesson Corp. stock rises Tuesday, still underperforms market - MarketWatch
Jim Cramer Says He ‘Would Not Buy’ McKesson Corporation (MCK) - Insider Monkey
The Zacks Analyst Blog Highlights Leidos, First American Financial, McKesson, The Gap and SkyWest - Zacks Investment Research
Are Investors Undervaluing McKesson (MCK) Right Now? - Yahoo Finance
Healthcare Distribution Market Projected To Witness Substantial Growth, 2024-2031: Consorta, Inc., McKesson - EIN News
With 89% institutional ownership, McKesson Corporation (NYSE:MCK) is a favorite amongst the big guns - Yahoo Finance
Mckesson Corporation Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):